Compile Data Set for Download or QSAR
Report error Found 207 Enz. Inhib. hit(s) with all data for entry = 1897
TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346341BDBM346341(US10202377, Compound 367)
Affinity DataIC50: 3.5nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346315BDBM346315(US10202377, Compound 269)
Affinity DataIC50: 4.20nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346283BDBM346283(US10202377, Compound 82)
Affinity DataIC50: 4.5nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346318BDBM346318(US10202377, Compound 280)
Affinity DataIC50: 6.20nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346320BDBM346320(US10202377, Compound 288)
Affinity DataIC50: 6.80nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346309BDBM346309(US10202377, Compound 238)
Affinity DataIC50: 7.70nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346319BDBM346319(US10202377, Compound 283)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346320BDBM346320(US10202377, Compound 288)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346316BDBM346316(US10202377, Compound 271)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346317BDBM346317(US10202377, Compound 277)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346324BDBM346324(US10202377, Compound 298)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346321BDBM346321(US10202377, Compound 292)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346322BDBM346322(US10202377, Compound 294)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346308BDBM346308(US10202377, Compound 234)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346314BDBM346314(US10202377, Compound 268)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346313BDBM346313(US10202377, Compound 265)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346341BDBM346341(US10202377, Compound 367)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346271BDBM346271(US10202377, Compound 13)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346269BDBM346269(US10202377, Compound 1)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346343BDBM346343(US10202377, Compound 379)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346336BDBM346336(US10202377, Compound 337)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346333BDBM346333(US10202377, Compound 325)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346358BDBM346358(US10202377, Compound 448)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346283BDBM346283(US10202377, Compound 82)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346356BDBM346356(US10202377, Compound 439)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346357BDBM346357(US10202377, Compound 442)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346286BDBM346286(US10202377, Compound 93)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346287BDBM346287(US10202377, Compound 101)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346285BDBM346285(US10202377, Compound 90)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346353BDBM346353(US10202377, Compound 427)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346279BDBM346279(US10202377, Compound 55)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346354BDBM346354(US10202377, Compound 433)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346351BDBM346351(US10202377, Compound 421)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346300BDBM346300(US10202377, Compound 190)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346298BDBM346298(US10202377, Compound 181)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346301BDBM346301(US10202377, Compound 196)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346302BDBM346302(US10202377, Compound 202)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346365BDBM346365(US10202377, Compound 939)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346296BDBM346296(US10202377, Compound 169)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346383BDBM346383(US10202377, Compound 1350)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346294BDBM346294(US10202377, Compound 154)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346379BDBM346379(US10202377, Compound 953)
Affinity DataEC50:  9nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346351BDBM346351(US10202377, Compound 421)
Affinity DataIC50: 10nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346272BDBM346272(US10202377, Compound 20)
Affinity DataEC50:  10nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346339BDBM346339(US10202377, Compound 358)
Affinity DataIC50: 11.6nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346324BDBM346324(US10202377, Compound 298)
Affinity DataIC50: 12.9nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346285BDBM346285(US10202377, Compound 90)
Affinity DataIC50: 13.9nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346342BDBM346342(US10202377, Compound 373)
Affinity DataEC50:  14nMAssay Description:Compound Screening: Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:2, 11-point d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346332BDBM346332(US10202377, Compound 321)
Affinity DataIC50: 16.3nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetProto-oncogene Wnt-1(Human)
Samumed

US Patent
LigandChemical structure of BindingDB Monomer ID 346326BDBM346326(US10202377, Compound 306)
Affinity DataIC50: 16.8nMAssay Description:The screening assay for Wnt activity is described as follows. Reporter cell lines can be generated by stably transducing cancer cell lines (e.g., col...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

Displayed 1 to 50 (of 207 total ) | Next | Last >>
Jump to: